SCHEMBL2999464

SCHEMBL2999464

C=C(C)CS(=O)(=O)CC(=C)C

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818606 0.88
SCHEMBL27703946 0.85
SCHEMBL9490818 0.81 CA2 (0.30)
SCHEMBL31738606 0.80 HSD17B10 (0.37) HSD17B10TDP1
SCHEMBL6737156 0.79
SCHEMBL14351663 0.78
SCHEMBL395642 0.78 HSD17B10 (0.35) HSD17B10TDP1
SCHEMBL26701 0.78
SCHEMBL92926 0.78
SCHEMBL127251 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245085-A1 TREATMENT COMPOSITION AND METHOD FOR TREATING A WATER SYSTEM ECOLAB USA INC. (US) 2025-11-27 WO claimed
WO-2025245085-A1 TREATMENT COMPOSITION AND METHOD FOR TREATING A WATER SYSTEM ECOLAB USA INC. (US) 2025-11-27 WO disclosed
EP-4100498-A1 CHITOSAN DERIVATIVES AS SOIL RELEASE AGENTS Henkel AG & Co. KGaA (DE) 2022-12-14 EP disclosed
WO-2022173003-A1 SHRINKAGE REDUCING AGENT AND CEMENT COMPOSITION 株式会社日本触媒 2022-08-18 WO disclosed
WO-2020045514-A1 PAPERMAKING ADDITIVE, PAPER, AND PAPER MANUFACTURING METHOD 星光PMC株式会社 2020-03-05 WO disclosed
US-10464776-B2 Method for manufacturing combined yarn bundle, and method for manufacturing carbon fiber in which resulting combined yarn bundle is used (as amended) TORAY INDUSTRIES, INC. (JP) 2019-11-05 US disclosed
EP-3290549-B1 METHOD FOR MANUFACTURING SPUN THREAD BUNDLE, AND METHOD FOR MANUFACTURING CARBON FIBER IN WHICH RESULTING SPUN THREAD BUNDLE IS USED TORAY INDUSTRIES (JP) 2019-10-16 EP disclosed
US-20180134510-A1 METHOD FOR MANUFACTURING COMBINED YARN BUNDLE, AND METHOD FOR MANUFACTURING CARBON FIBER IN WHICH RESULTING COMBINED YARN BUNDLE IS USED (AS AMENDED) TORAY INDUSTRIES, INC. (JP) 2018-05-17 US disclosed
EP-3290549-A1 METHOD FOR MANUFACTURING SPUN THREAD BUNDLE, AND METHOD FOR MANUFACTURING CARBON FIBER IN WHICH RESULTING SPUN THREAD BUNDLE IS USED Toray Industries, Inc. (JP) 2018-03-07 EP disclosed
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES CIBA CORPORATION (NY) 2010-06-10 US disclosed
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES CIBA CORPORATION (NY) 2010-06-10 US disclosed
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES CIBA CORPORATION (NY) 2010-06-10 US disclosed
EP-2122739-A1 NITROXIDES FOR LITHIUM-ION BATTERIES BASF SE (DE) 2009-11-25 EP disclosed
WO-2008110466-A1 NITROXIDES FOR LITHIUM-ION BATTERIES BASF SE (CH) 2008-09-18 WO disclosed
EP-1432678-A1 HIV PROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-06-30 EP disclosed
WO-2003029206-A1 PREPARATION OF HIV PROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-10 WO disclosed
US-4061631-A STABILIZER CIBA-GEIGY CORPORATION (US) 1977-12-06 US disclosed
US-3943098-A 1-Aza-4-thiacyclohexane-4,4-dioxide derivatives and their use as agents protecting against light rays CIBA-GEIGY CORPORATION (US) 1976-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES OGG1, NOX4, NQO1 POLB 1097/4885HSD17B10 1553/4885TDP1 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.